Figy v. Lifeway Foods, Inc.
Filing
46
ORDER vacating hearing and setting case management conference. Case management statement due by 1/19/2015. Case management conference set for 1/26/2015 01:30 PM in Courtroom 12, 19th Floor, San Francisco. Signed by Judge Thelton E. Henderson on 10/21/2014. (tehlc1, COURT STAFF) (Filed on 10/21/2014)
1
UNITED STATES DISTRICT COURT
2
NORTHERN DISTRICT OF CALIFORNIA
3
4
ROBERT E. FIGY,
Plaintiff,
5
6
7
8
v.
LIFEWAY FOODS, INC.,
Case No. 13-cv-04828-TEH
ORDER VACATING HEARING AND
SETTING CASE MANAGEMENT
CONFERENCE
Defendant.
9
On May 5, 2014, the Court stayed proceedings in this case under the primary
11
United States District Court
Northern District of California
10
jurisdiction doctrine because the Food and Drug Administration (“FDA”) reopened public
12
comment on the use of the term Evaporated Cane Juice (“ECJ”), the ingredient at issue in
13
this case. May 5, 2014 Order at 10 (Docket No. 44). At that time, the Court set a
14
compliance hearing on November 3, 2014, to determine whether the stay should be lifted.
15
Id. As instructed, the parties provided a joint statement outlining their positions on this
16
matter. Joint Statement (Docket No. 45). For the reasons set forth below, the November 3
17
compliance hearing is VACATED and the stay remains in effect.
18
19
20
DISCUSSION
The FDA has not yet issued its final guidance on this issue. Joint Statement at 1.
21
The Court concludes that the same reasons for applying the primary jurisdiction doctrine in
22
May still apply at this time. In short, by staying this case until the FDA issues final
23
guidance, the Court enhances its decision-making efficiency and ensures the uniform
24
application of regulatory law. Order at 7.
25
The Court is not persuaded by Plaintiff’s argument that the Supreme Court decision
26
(much less amicus briefs) in POM Wonderful LLC v. Coca-Cola Co., 134 S. Ct. 2228
27
(2014), requires lifting the stay at this time. In that case, the Court held that an unfair
28
competition claim under the Lanham Act was not precluded by the FDA’s regulatory
1
authority under the Food, Drug and Cosmetic Act (“FDCA”). Id. at 2238-41. The Court
2
did not discuss the primary jurisdiction doctrine. See id. The question of whether a case
3
can be brought is separate from whether it should be heard right now. The Supreme
4
Court’s preclusion holding does not alter this Court’s prudential application of the primary
5
jurisdiction doctrine in order to promote judicial efficiency and uniformity.
6
Nonetheless, the Court recognizes that the parties do not yet know with certainty
when, or even if, the FDA will promulgate final guidance on this issue. Although the
8
Court previously concluded that the FDA is likely to make a final pronouncement, that
9
conclusion is somewhat undermined by the passage of time. A prolonged delay may
10
prejudice Plaintiff, weighing against applying the primary jurisdiction doctrine in the
11
United States District Court
Northern District of California
7
future. See Swearingen v. Amazon Pres. Partners, Inc., No. 13-cv-04402-WHO, 2014 WL
12
3934000 at *2 (Aug. 11, 2014) (“[I]t seems possible that the FDA will issue final guidance
13
this year. A modest stay at this time will not prejudice plaintiffs.”). However, the Court
14
sees no reason to conclude that Plaintiff faces a risk of prejudice at this point.
15
16
17
CONCLUSION
Accordingly, the hearing set for November 3, 2014 is VACATED and the action
18
remains STAYED. A case management conference shall be held on January 26, 2015, at
19
1:30 PM to apprise the Court of the status of this matter. The parties shall file a joint
20
statement of no more than six pages by January 19, 2015, updating the Court on the status
21
of the FDA’s action with respect to the ECJ guidance and the parties’ positions as to
22
whether the stay shall remain in effect.
23
24
IT IS SO ORDERED.
25
26
27
Dated: 10/21/2014
_____________________________________
THELTON E. HENDERSON
United States District Judge
28
2
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?